Abstract
A 5-year-old girl with Landau–Kleffner syndrome is discussed. The child began having seizures at age 4 associated with language deterioration despite anticonvulsant therapy. With levetiracetam monotherapy to a dose of 60 mg/kg/day and discontinuation of carbamazepine and valproic acid, her language has improved and seizures are controlled. Levetiracetam should be considered as therapy for Landau–Kleffner syndrome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have